RWP
TMO icon

Revolve Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Revolve Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Sell
553
-8
-1% -$3.84K 0.03% 286
2026
Q1 		$276K Sell
561
-49
-8% -$26.6K 0.04% 188
2025
Q4 		$353K Buy
610
+73
+14% +$41.3K 0.04% 165
2025
Q3 		$260K Buy
+537
New +$250K 0.03% 189
2025
Q2 		– Sell
-477
Closed -$237K – 239
2025
Q1 		$237K Sell
477
-14
-3% -$7.58K 0.03% 195
2024
Q4 		$255K Buy
491
+20
+4% +$11K 0.04% 184
2024
Q3 		$291K Buy
471
+28
+6% +$16.6K 0.04% 154
2024
Q2 		$245K Buy
443
+10
+2% +$5.73K 0.04% 153
2024
Q1 		$251K Buy
433
+55
+15% +$30.9K 0.04% 150
2023
Q4 		$200K Sell
378
-89
-19% -$43.1K 0.04% 161
2023
Q3 		$236K Buy
467
+46
+11% +$24.5K 0.05% 129
2023
Q2 		$219K Sell
421
-41
-9% -$22.1K 0.05% 133
2023
Q1 		$266K Sell
462
-56
-11% -$31.6K 0.07% 118
2022
Q4 		$285K Buy
+518
New +$274K 0.08% 110
2022
Q1 		– Sell
-307
Closed -$205K – 157
2021
Q4 		$205K Buy
+307
New +$192K 0.06% 144

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Revolve Wealth Partners's TMO Position: Q2 2026 in Review

Revolve Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 1.4% in Q2 2026, selling an estimated $3.84K and leaving 553 shares worth $277K. The position accounts for 0.03% of the portfolio, ranked #286.

Revolve Wealth Partners first reported a position in TMO in Q4 2021 and has held it in 15 quarters since. The position peaked at $353K in Q4 2025. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Revolve Wealth Partners held 553 shares of Thermo Fisher Scientific worth $277K as of Q2 2026.
  • Revolve Wealth Partners sold 8 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.84K.
  • Thermo Fisher Scientific made up 0.03% of Revolve Wealth Partners's portfolio in Q2 2026, its #286 holding.
  • Revolve Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 15 quarters since.
  • Revolve Wealth Partners's Thermo Fisher Scientific position peaked at $353K in Q4 2025.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Revolve Wealth Partners's 13F filing for Q2 2026, filed 9 Jul 2026.